Clinical variates | Group A | Group B | P-value |
---|---|---|---|
Treated with anti-MRSA drugs | Treated without anti-MRSA drugs | ||
(n = 13) | (n = 29) | ||
Age ± SD (years) | 74.8 ± 10.1 | 74.6 ± 17.5 | 0.764 |
Male: Female | 10:3 | 19:10 | 0.458 |
Underlying diseases** | |||
None | 2 (15.4 %) | 4 (13.8 %) | 0.898 |
Malignancies | 1 (7.7 %) | 11 (37.9 %) | 0.016 |
Cerebrovascular disorders | 5 (38.5 %) | 10 (34.5 %) | 0.813 |
Chronic pulmonary diseases | 4 (30.8 %) | 5 (17.2 %) | 0.382 |
COPD | 2 (15.4 %) | 2 (6.9 %) | 0.469 |
Bronchiectasis/NTM | 1 (7.7 %) | 5 (17.2 %) | 0.370 |
Interstitial lung diseases | 1 (7.7 %) | 1 (3.4 %) | 0.621 |
Diabetes mellitus | 4 (30.8 %) | 3 (10.3 %) | 0.178 |
Dementia | 4 (30.8 %) | 6 (20.7 %) | 0.519 |
Heart diseases | 4 (30.8 %) | 5 (17.2 %) | 0.382 |
Hepatic diseases | 1 (7.7 %) | 1 (3.4 %) | 0.621 |
Renal diseases | 1 (7.7 %) | 4 (13.8 %) | 0.550 |
Hematology/Collagen-vascular diseases | 1 (7.7 %) | 4 (13.8 %) | 0.550 |
ECOG performance status 3-4 | 75.0 % (9/12) | 60.0 % (15/25) | 0.371 |
Use of Glucocorticoid**/Immunosuppresant | 1 (7.7 %) | 5 (17.2 %) | 0.37 |
Use of gastric tube | 1 (7.7 %) | 2 (6.9 %) | 0.931 |
Histories/Risks of aspiration | 8 (61.5 %) | 15 (51.7 %) | 0.568 |
Antibiotic therapy in the preceding 90 days | 5 (38.5 %) | 7 (24.1 %) | 0.387 |
History of MRSA detection in the preceding 90 days | 4 (30.8 %) | 5 (17.2 %) | 0.382 |
Type of pneumonia | |||
CAP | 0 (0.0 %) | 2 (6.9 %) | 0.161 |
HCAP | 2 (15.4 %) | 15 (51.7 %) | 0.015 |
HAP | 11 (84.6 %) | 12 (41.3 %) | 0.099 |
Radiologic findings of Chest CT* | |||
Consolidation | 7 (63.6 %) | 12 (41.4 %) | 0.474 |
Bronchopneumonia | 1 (9.1 %) | 9 (31.0 %)) | 0.052 |
Complicated with cavitation/abscess formation | 0 (0.0 %) | 0 (0.0 %) | – |
Complicated with atelectasis | 0 (0.0 %) | 3 (10.3 %) | 0.083 |
Centrilobular nodules (DPB-like) | 0 (0.0 %) | 0 (0.0 %) | – |
Diffuse alveolar shadow (ARDS-like) | 2 (18.2 %) | 0 (0.0 %) | 0.165 |
Bronchiectasis | 1 (9.1 %) | 6 (20.7 %) | 0.239 |
Parapneumonic pleural effusion | 5 (45.5 %) | 3 (10.3 %) | 0.082 |